期刊文献+

安神一号胶囊与劳拉西泮治疗躯体形式障碍自主神经紊乱的疗效比较

Clinical Study on Treating Patients with Somatoform Disorder and Autonomic Nervous Disorder with AnShenYiHao Capsule or Lorazepam
下载PDF
导出
摘要 目的:比较安神一号胶囊与劳拉西泮治疗躯体形式障碍自主神经紊乱的疗效。方法:将90例躯体形式障碍自主神经紊乱住院患者随机分为2组,安神一号胶囊组与劳拉西泮组各45例,治疗8周,采用Hamilton Anxiety Scale(HAMA)和Clinical Global Impres GIon-global improvement(CGIGI)评定临床疗效。结果:安神一号胶囊与劳拉西泮有效率分别为:86.66%和82.22%,2组疗效差异无统计学意义(P>0.05)。结论:安神一号胶囊与劳拉西泮治疗躯体形式障碍自主神经紊乱疗效相当。 Objective:To compare the efficacy of treating patients with somatoform disorder and autonomic nervous disorder with AnShen YiHao capsule or lorazepam.Method:90 cases of patients with somatoform disorder and autonomic nervous disorder were randomly divided into two groups,each group had 45 cases and treated for 8 weeks,one group were treated with lorazepam and another group were treated with AnShen YiHao capsule,assessed the clinical efficacy using(Hamilton Anxiety Scale,HAMA) and(Clinical Global ImpresGIon-global improvement,CGI-GI).Result:The total effective rates of the AnShen YiHao capsule group and the lorazepam group were 86.66% and 82.22% after 8 weeks of treatment,the differences in efficacy between two groups had no significant difference(P0.05). Conclusion:AnShen YiHao capsule and lorazepam have considerable effect on treating patients with somatoform disorder and autonomic nervous disorder.
出处 《西部中医药》 2011年第9期10-12,共3页 Western Journal of Traditional Chinese Medicine
基金 甘肃省科学事业项目(编号QS022-C33-005)
关键词 安神一号胶囊 劳拉西泮 躯体形式障碍自主神经紊乱 AnShen YiHao capsule lorazepam somatoform disorder and autonomic nervous disorder
  • 相关文献

参考文献11

二级参考文献33

  • 1薛启蓂.代谢、营养和中毒性周围神经病[J].中国临床神经科学,2009,17(1):58-71. 被引量:3
  • 2许俭兴,谭杰文,区丽明.氟西汀和阿米替林治疗抑郁和焦虑障碍共病的疗效比较[J].中国临床康复,2004,8(15):2812-2814. 被引量:4
  • 3于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 4杨雪琴,李炜,李铀,王毅侠,邢华雄,俞梦孙.心率变异性作为植物神经功能检查方法的探讨[J].北京生物医学工程,1996,15(2):65-70. 被引量:14
  • 5张明圆.精神科评定量表[M].长沙:湖南科学技术出版社,1993.16-24.
  • 6Vienken J.How can liver toxins be removed?Filtration and adsorption with the Prometheus system[J].Ther Apher Dial,2006,10(2):125-131.
  • 7Brouns R,De Deyn PP.Neurological complications in renal failure[J].Clinical Neurology and Neuresurgery,2004,107:1-16.
  • 8Krishnan AV.Uremic neuropathy:clinical features and new pathophysiological insights[J].Muscle Nerve,2007,35(3):273-290.
  • 9Hamid Nasril,Azar Baradaran Z,Amir Said Alizadeh Naderi.Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis[J].Acta Medica Austliaca,2004,31(3):67-72.
  • 10Gwidon Polak,Strozecki,Grzegorz Grzesk,et al.Effect of parathormone on heart rate variability in hemodialysis patients[J].Autonomic Neuroscience:Basic and Clinical,2004,115:94-98.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部